Alkaloids from the entheogenic plant Peganum harmala

References

[1]  MP Bogenschutz, MW Johnson, Classic hallucinogens in the treatment of addictions. Prog Neuropsychopharmacol Biol Psychiatry 2016, 64, 250.
         | Classic hallucinogens in the treatment of addictions.Crossref | GoogleScholarGoogle Scholar |

[2]  AK Davis, JP Barsuglia, R Lancelotta, RM Grant, E Renn, The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: benefits, consequences, patterns of use, subjective effects, and reasons for consumption. J Psychopharmacol 2018, 32, 779.
         | The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: benefits, consequences, patterns of use, subjective effects, and reasons for consumption.Crossref | GoogleScholarGoogle Scholar |

[3]  MV Uthaug, R Lancelotta, K van Oorsouw, KPC Kuypers, N Mason, J Rak, A Šuláková, R Jurok, M Maryška, M Kuchař, T Páleníček, J Riba, JG Ramaekers, A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology 2019, 236, 2653.
         | A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.Crossref | GoogleScholarGoogle Scholar |

[4]  MV Uthaug, R Lancelotta, A Szabo, AK Davis, J Riba, JG Ramaekers, Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment. Psychopharmacology 2020, 237, 773.
         | Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.Crossref | GoogleScholarGoogle Scholar |

[5]  G Agin-Liebes, TF Haas, R Lancelotta, MV Uthaug, JG Ramaekers, AK Davis, Naturalistic use of mescaline is associated with self-reported psychiatric improvements and enduring positive life changes. ACS Pharmacol Transl Sci 2021, 4, 543.
         | Naturalistic use of mescaline is associated with self-reported psychiatric improvements and enduring positive life changes.Crossref | GoogleScholarGoogle Scholar |

[6]  A Zięba, P Stępnicki, D Matosiuk, AA Kaczor, Overcoming depression with 5-HT2A receptor ligands. Int J Mol Sci 2021, 23, 10.
         | Overcoming depression with 5-HT_2A receptor ligands.Crossref | GoogleScholarGoogle Scholar |

[7]  N-X Li, Y-R Hu, W-N Chen, B Zhang, Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. J Affect Disord 2022, 296, 26.
         | Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar |

[8]  H Lowe, N Toyang, B Steele, J Grant, A Ali, L Gordon, W Ngwa, Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders. Molecules 2022, 27, 2520.
         | Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders.Crossref | GoogleScholarGoogle Scholar |

[9]  MV Uthaug, AK Davis, TF Haas, D Davis, SB Dolan, R Lancelotta, C Timmermann, JG Ramaekers, The epidemiology of mescaline use: pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. J Psychopharmacol 2022, 36, 309.
         | The epidemiology of mescaline use: pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.Crossref | GoogleScholarGoogle Scholar |

[10]  N Schimmel, JJ Breeksema, SY Smith-Apeldoorn, J Veraart, W van den Brink, RA Schoevers, Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review. Psychopharmacology 2022, 239, 15.
         | Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.Crossref | GoogleScholarGoogle Scholar |

[11]  Grob CS, Grigsby J. Handbook of Medical Hallucinogens. Guilford Publications; 2022.

[12]  K Ko, EI Kopra, AJ Cleare, JJ Rucker, Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis. J Affect Disord 2023, 322, 194.
         | Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar |

[13]  J González-Maeso, NV Weisstaub, M Zhou, P Chan, L Ivic, R Ang, A Lira, M Bradley-Moore, Y Ge, Q Zhou, SC Sealfon, JA Gingrich, Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. Neuron 2007, 53, 439.
         | Hallucinogens recruit specific cortical 5-HT_2A receptor-mediated signaling pathways to affect behavior.Crossref | GoogleScholarGoogle Scholar |

[14]  S Karaki, C Becamel, S Murat, C Mannoury la Cour, MJ Millan, L Prézeau, J Bockaert, P Marin, F Vandermoere, Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. Mol Cell Proteomics 2014, 13, 1273.
         | Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser²⁸⁰ by hallucinogenic versus nonhallucinogenic agonists.Crossref | GoogleScholarGoogle Scholar |

[15]  AC Kwan, DE Olson, KH Preller, BL Roth, The neural basis of psychedelic action. Nat Neurosci 2022, 25, 1407.
         | The neural basis of psychedelic action.Crossref | GoogleScholarGoogle Scholar |

[16]  H Morris, J Wallach, From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 2014, 6, 614.
         | From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.Crossref | GoogleScholarGoogle Scholar |

[17]  AM Lakstygal, TO Kolesnikova, SL Khatsko, KN Zabegalov, AD Volgin, KA Demin, VA Shevyrin, EA Wappler-Guzzetta, AV Kalueff, DARK classics in chemical neuroscience: atropine, scopolamine, and other anticholinergic deliriant hallucinogens. ACS Chem Neurosci 2019, 10, 2144.
         | DARK classics in chemical neuroscience: atropine, scopolamine, and other anticholinergic deliriant hallucinogens.Crossref | GoogleScholarGoogle Scholar |

[18]  C Sanz, F Zamberlan, E Erowid, F Erowid, E Tagliazucchi, The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports. Front Neurosci 2018, 12, 7.
         | The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports.Crossref | GoogleScholarGoogle Scholar |

[19]  AD Volgin, OA Yakovlev, KA Demin, PA Alekseeva, EJ Kyzar, C Collins, DE Nichols, AV Kalueff, Understanding central nervous system effects of deliriant hallucinogenic drugs through experimental animal models. ACS Chem Neurosci 2019, 10, 143.
         | Understanding central nervous system effects of deliriant hallucinogenic drugs through experimental animal models.Crossref | GoogleScholarGoogle Scholar |

[20]  CW Cunningham, RB Rothman, TE Prisinzano, Neuropharmacology of the naturally occurring κ-opioid hallucinogen salvinorin A. Pharmacol Rev 2011, 63, 316.
         | Neuropharmacology of the naturally occurring κ-opioid hallucinogen salvinorin A.Crossref | GoogleScholarGoogle Scholar |

[21]  M Moloudizargari, P Mikaili, S Aghajanshakeri, M Asghari, J Shayegh, Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn Rev 2013, 7, 199.
         | Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids.Crossref | GoogleScholarGoogle Scholar |

[22]  D Khlifi, RM Sghaier, S Amouri, D Laouini, M Hamdi, J Bouajila, Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L. and Peganum harmala L. Food Chem Toxicol 2013, 55, 202.
         | Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L. and Peganum harmala L.Crossref | GoogleScholarGoogle Scholar |

[23]  Passos ID, Mironidou-Tzouveleki M. Chapter 71 – Hallucinogenic plants in the Mediterranean countries. Neuropathology of Drug Addictions and Substance Misuse. Elsevier; 2016. pp. 761–772.
| Crossref |

[24]  MD Merlin, Archaeological evidence for the tradition of psychoactive plant use in the old world. Econ Bot 2003, 57, 295.
         | Archaeological evidence for the tradition of psychoactive plant use in the old world.Crossref | GoogleScholarGoogle Scholar |

[25]  Ott J. Ayahuasca Analogues: Pangæan Entheogens. Jonathan Ott Books; 1994.

[26]  HU Sayin, The consumption of psychoactive plants in ancient global and Anatolian cultures during religious rituals: the roots of the eruption of mythological figures and common symbols in religions and myths. Neuroquantology 2014, 12, 276.
         | The consumption of psychoactive plants in ancient global and Anatolian cultures during religious rituals: the roots of the eruption of mythological figures and common symbols in religions and myths.Crossref | GoogleScholarGoogle Scholar |

[27]  G Ona, S Troncoso, Long-lasting analgesic effect of the psychedelic drug changa: a case report. J Psychedelic Stud 2019, 3, 7.
         | Long-lasting analgesic effect of the psychedelic drug changa: a case report.Crossref | GoogleScholarGoogle Scholar |

[28]  J Asgarpanah, F Ramezanloo, Chemistry, pharmacology and medicinal properties of Peganum harmala L. Afr J Pharm Pharmacol 2012, 6, 1573.
         | Chemistry, pharmacology and medicinal properties of Peganum harmala L.Crossref | GoogleScholarGoogle Scholar |

[29]  G Frison, D Favretto, F Zancanaro, G Fazzin, SD Ferrara, A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci Int 2008, 179, e37.
         | A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract.Crossref | GoogleScholarGoogle Scholar |

[30]  A Yuruktumen, S Karaduman, F Bengi, J Fowler, Syrian rue tea: a recipe for disaster. Clin Toxicol 2008, 46, 749.
         | Syrian rue tea: a recipe for disaster.Crossref | GoogleScholarGoogle Scholar |

[31]  M Moshiri, L Etemad, S Javidi, A Alizadeh, Peganum harmala intoxication, a case report. Avicenna J Phytomed 2013, 3, 288.

[32]  EA Ghizlane, M Manal, HA Ines, D Soufiane, L Moussa, B Houssam, H Brahim, Fatal poisoning of pregnant women by Peganum harmala L.: a case reports. Ann Med Surg 2021, 68, 102649.
         | Fatal poisoning of pregnant women by Peganum harmala L.: a case reports.Crossref | GoogleScholarGoogle Scholar |

[33]  MA Berdai, S Labib, M Harandou, Peganum harmala L. intoxication in a pregnant woman. Case Rep Emerg Med 2014, 2014, 1.
         | Peganum harmala L. intoxication in a pregnant woman.Crossref | GoogleScholarGoogle Scholar |

[34]  S Achour, N Rhalem, A Khattabi, H Lofti, A Mokhtari, A Soulaymani, A Turcant, RS Bencheikh, L’intoxication au Peganum harmala L. au Maroc : à propos de 200 cas. Therapies 2012, 67, 53.
         | L’intoxication au Peganum harmala L. au Maroc : à propos de 200 cas.Crossref | GoogleScholarGoogle Scholar |

[35]  SS Bharate, S Mignani, RA Vishwakarma, Why are the majority of active compounds in the CNS domain natural products? A critical analysis. J Med Chem 2018, 61, 10345.
         | Why are the majority of active compounds in the CNS domain natural products? A critical analysis.Crossref | GoogleScholarGoogle Scholar |

[36]  S Li, X Cheng, C Wang, A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum. J Ethnopharmacol 2017, 203, 127.
         | A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum.Crossref | GoogleScholarGoogle Scholar |

[37]  J Sharifi-Rad, C Quispe, J Herrera-Bravo, P Semwal, S Painuli, B Özçelik, FE Hacıhasanoğlu, S Shaheen, S Sen, K Acharya, M Amirian, CMS Castillo, MD López, M Schoebitz, M Martorell, T Goloshvili, A Al-Harrasi, A Al-Rawahi, M Kumar, HAR Suleria, WC Cho, Peganum spp.: a comprehensive review on bioactivities and health-enhancing effects and their potential for the formulation of functional foods and pharmaceutical drugs. Oxid Med Cell Longev 2021, 2021, e5900422.
         | Peganum spp.: a comprehensive review on bioactivities and health-enhancing effects and their potential for the formulation of functional foods and pharmaceutical drugs.Crossref | GoogleScholarGoogle Scholar |

[38]  MC Niroumand, MH Farzaei, G Amin, Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review. J Tradit Chin Med 2015, 35, 104.
         | Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review.Crossref | GoogleScholarGoogle Scholar |

[39]  A Shahverdi, S Ostad, S Khodaee, L Bitarafan, H Monsef-Esfahani, H Jamalifar, B Nikavar, M Mohseni, Antimicrobial and cytotoxicity potential of Peganum harmala smoke. Pharmacogn Mag 2008, 4, 236.

[40]  Y Yang, X Cheng, W Liu, G Chou, Z Wang, C Wang, Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation. J Ethnopharmacol 2015, 168, 279.
         | Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation.Crossref | GoogleScholarGoogle Scholar |

[41]  D Sassoui, R Seridi, K Azin, M Usai, Evaluation of phytochemical constituents by GC-MS and antidepressant activity of Peganum harmala L. seeds extract. Asian Pac J Trop Dis 2015, 5, 971.
         | Evaluation of phytochemical constituents by GC-MS and antidepressant activity of Peganum harmala L. seeds extract.Crossref | GoogleScholarGoogle Scholar |

[42]  C Wang, Z Zhang, Y Wang, X He, Cytotoxic indole alkaloids against human leukemia cell lines from the toxic plant Peganum harmala. Toxins 2015, 7, 4507.
         | Cytotoxic indole alkaloids against human leukemia cell lines from the toxic plant Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[43]  X Fang, H-Y Yu, L-F Han, X Pang, N‐containing compounds from seeds of Peganum harmala. Zhongguo Zhong Yao Za Zhi 2019, 44, 1601.[In Chinese]
         | N‐containing compounds from seeds of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[44]  M Shonouda, S Osman, O Salama, A Ayoub, Toxical effect of Peganum harmala L. leaves on the cotton leaf worm, Spodoptera littoralis Boisd and its parasitoids Microplitis rufiventris Kok. Pak J Biol Sci 2008, 11, 546.
         | Toxical effect of Peganum harmala L. leaves on the cotton leaf worm, Spodoptera littoralis Boisd and its parasitoids Microplitis rufiventris Kok.Crossref | GoogleScholarGoogle Scholar |

[45]  E Mckenzie, L Nettleship, M Slaytor, New natural products from Peganum harmala. Phytochemistry 1975, 14, 273.
         | New natural products from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[46]  K-B Wang, X Hu, S-G Li, X-Y Li, D-H Li, J Bai, Y-H Pei, Z-L Li, H-M Hua, Racemic indole alkaloids from the seeds of Peganum harmala. Fitoterapia 2018, 125, 155.
         | Racemic indole alkaloids from the seeds of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[47]  K-B Wang, D-H Li, P Hu, W-J Wang, C Lin, J Wang, B Lin, J Bai, Y-H Pei, Y-K Jing, Z-L Li, D Yang, H-M Hua, A series of β-carboline alkaloids from the seeds of Peganum harmala show G-Quadruplex interactions. Org Lett 2016, 18, 3398.
         | A series of β-carboline alkaloids from the seeds of Peganum harmala show G-Quadruplex interactions.Crossref | GoogleScholarGoogle Scholar |

[48]  CL Schmid, LM Bohn, Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a β-arrestin2/Src/Akt signaling complex in vivo. J Neurosci 2010, 30, 13513.
         | Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a β-arrestin2/Src/Akt signaling complex in vivo.Crossref | GoogleScholarGoogle Scholar |

[49]  J Axelrod, The enzymatic N-methylation of serotonin and other amines. J Pharmacol Exp Ther 1962, 138, 28.

[50]  RA Glennon, PK Gessner, Serotonin receptor binding affinities of tryptamine analogs. J Med Chem 1979, 22, 428.
         | Serotonin receptor binding affinities of tryptamine analogs.Crossref | GoogleScholarGoogle Scholar |

[51]  MC McBride, Bufotenine: toward an understanding of possible psychoactive mechanisms. J Psychoactive Drugs 2000, 32, 321.
         | Bufotenine: toward an understanding of possible psychoactive mechanisms.Crossref | GoogleScholarGoogle Scholar |

[52]  Chu A, Wadhwa R. StatPearls. Treasure Island, FL: StatPearls Publishing; 2022.

[53]  R Kumagai, T Ohnuma, T Nagata, H Arai, Visual and auditory hallucinations with excessive intake of paroxetine. Psychiatry Clin Neurosci 2003, 57, 548.
         | Visual and auditory hallucinations with excessive intake of paroxetine.Crossref | GoogleScholarGoogle Scholar |

[54]  S Shimizu, K Watanabe, I Jibiki, Auditory hallucinations associated with clinical dosage of paroxetine: a case report. Psychiatry Clin Neurosci 2010, 64, 666.
         | Auditory hallucinations associated with clinical dosage of paroxetine: a case report.Crossref | GoogleScholarGoogle Scholar |

[55]  K-B Wang, D-H Li, Y Bao, F Cao, W-J Wang, C Lin, W Bin, J Bai, Y-H Pei, Y-K Jing, D Yang, Z-L Li, H-M Hua, Structurally diverse alkaloids from the seeds of Peganum harmala. J Nat Prod 2017, 80, 551.
         | Structurally diverse alkaloids from the seeds of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[56]  BKh Zharekeev, KhN Khashimov, MV Telezhenetskaya, SYu Yunusov, New alkaloids from Peganum harmala. Chem Nat Compd 1974, 10, 282.
         | New alkaloids from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[57]  Q Zhang, Y-H Zan, H-G Yang, M-Y Yang, F-S Liu, S-G Li, X-H Peng, B Lin, Z-L Li, D-H Li, H-M Hua, Anti-tumor alkaloids from Peganum harmala. Phytochemistry 2022, 197, 113107.
         | Anti-tumor alkaloids from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[58]  JA Inger, ER Mihan, JU Kolli, CW Lindsley, AM Bender, DARK classics in chemical neuroscience: methaqualone. ACS Chem Neurosci 2023, 14, 340.
         | DARK classics in chemical neuroscience: methaqualone.Crossref | GoogleScholarGoogle Scholar |

[59]  Johne S. Chapter 2: Quinazoline alkaloids. The Alkaloids: Chemistry and Pharmacology. Vol. 29. Elsevier; 1986. pp. 99–140. https://doi.org/10.1016/S0099-9598(08)60247-3

[60]  WE Hanford, R Adams, The structure of vasicine. II. Synthesis of desoxyvasicine. J Am Chem Soc 1935, 57, 921.
         | The structure of vasicine. II. Synthesis of desoxyvasicine.Crossref | GoogleScholarGoogle Scholar |

[61]  E Späth, F Kuffner, N Platzer, Die Konstitution von Peganin (Vasicin). Ber Dtsch Chem Ges 1935, 68, 497.[In German]
         | Die Konstitution von Peganin (Vasicin).Crossref | GoogleScholarGoogle Scholar |

[62]  T Herraiz, H Guillén, VJ Arán, A Salgado, Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala. Food Chem Toxicol 2017, 103, 261.
         | Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[63]  W Liu, Y Wang, D He, S Li, Y Zhu, B Jiang, X Cheng, Z Wang, C Wang, Antitussive, expectorant, and bronchodilating effects of quinazoline alkaloids (±)-vasicine, deoxyvasicine, and (±)-vasicinone from aerial parts of Peganum harmala L. Phytomedicine 2015, 22, 1088.
         | Antitussive, expectorant, and bronchodilating effects of quinazoline alkaloids (±)-vasicine, deoxyvasicine, and (±)-vasicinone from aerial parts of Peganum harmala L.Crossref | GoogleScholarGoogle Scholar |

[64]  AL D’yakonov, MV Telezhenetskaya, Quinazoline alkaloids in nature Chem Nat Compd 1997, 33, 221.
         | Quinazoline alkaloids in natureCrossref | GoogleScholarGoogle Scholar |

[65]  A Astulla, K Zaima, Y Matsuno, Y Hirasawa, W Ekasari, A Widyawaruyanti, NC Zaini, H Morita, Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities. J Nat Med 2008, 62, 470.
         | Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities.Crossref | GoogleScholarGoogle Scholar |

[66]  ТС Туляганов, НМ Козимова, СА Султанов, New alkaloids of Peganum harmala (Peganaceae). Растительные Ресурсы 2008, 44, 82.[In Russian]

[67]  BKh Zharekeev, MV Telezhenetskaya, SYu Yunusov, Deoxypeganidine — a new alkaloid from Peganum harmala. Chem Nat Compd 1973, 9, 272.
         | Deoxypeganidine — a new alkaloid from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[68]  KhN Khashimov, MV Telezhenetskaya, SYu Yunusov, Peganidine – a new base from Peganum harmala. Chem Nat Compd 1969, 5, 518.
         | Peganidine – a new base from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[69]  MV Telezhenetskaya, KhN Khashimov, SYu Yunusov, Peganol – a new alkaloid from Peganum harmala. Chem Nat Compd 1971, 7, 835.
         | Peganol – a new alkaloid from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[70]  RYa Okmanov, B Tashkhodzhaev, ZM Khakimova, TS Tulyaganov, KhM Shakhidoyatov, Crystal structures of vasicinone and peganidine hydrochloride. Chem Nat Compd 2010, 46, 59.
         | Crystal structures of vasicinone and peganidine hydrochloride.Crossref | GoogleScholarGoogle Scholar |

[71]  S-G Li, K-B Wang, C Gong, Y Bao, N-B Qin, D-H Li, Z-L Li, J Bai, H-M Hua, Cytotoxic quinazoline alkaloids from the seeds of Peganum harmala. Bioorg Med Chem Lett 2018, 28, 103.
         | Cytotoxic quinazoline alkaloids from the seeds of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[72]  M Jain, V Sharma, Phytochemical investigation of roots of Adhatoda vasica. Planta Med 1982, 46, 250.
         | Phytochemical investigation of roots of Adhatoda vasica.Crossref | GoogleScholarGoogle Scholar |

[73]  T Nomura, Z-Z Ma, Y Hano, Y-J Chen, Two new quinazoline–quinoline alkaloids from Peganum nigellastrum. Heterocycles 1999, 51, 1883.
         | Two new quinazoline–quinoline alkaloids from Peganum nigellastrum.Crossref | GoogleScholarGoogle Scholar |

[74]  SB Mhaske, NP Argade, Biogenetic synthesis of luotonin F. Synthesis 2002, 2002, 323.
         | Biogenetic synthesis of luotonin F.Crossref | GoogleScholarGoogle Scholar |

[75]  Y Yang, X Cheng, W Liu, Z Han, G Chou, Y Wang, D Sun, Z Wang, C Wang, Peganumine B-I and two enantiomers: new alkaloids from the seeds of Peganum harmala Linn. and their potential cytotoxicity and cholinesterase inhibitory activities. RSC Adv 2016, 6, 15976.
         | Peganumine B-I and two enantiomers: new alkaloids from the seeds of Peganum harmala Linn. and their potential cytotoxicity and cholinesterase inhibitory activities.Crossref | GoogleScholarGoogle Scholar |

[76]  MF Faskhutdinov, MV Telezhenetskaya, MG Levkovich, ND Abdullaev, Alkaloids of Peganum harmala. Chem Nat Compd 2000, 36, 602.
         | Alkaloids of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[77]  KhN Khashimov, MV Telezhenetskaya, YaV Rashkes, SYu Yunusov, Pegamine: a new alkaloid from Peganum harmala. Chem Nat Compd 1970, 6, 462.
         | Pegamine: a new alkaloid from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[78]  Z Wang, D Kang, X Jia, H Zhang, J Guo, C Liu, Q Meng, W Liu, Analysis of alkaloids from Peganum harmala L. sequential extracts by liquid chromatography coupled to ion mobility spectrometry. J Chromatogr B 2018, 1096, 73.
         | Analysis of alkaloids from Peganum harmala L. sequential extracts by liquid chromatography coupled to ion mobility spectrometry.Crossref | GoogleScholarGoogle Scholar |

[79]  C-H Wang, H Zeng, Y-H Wang, C Li, J Cheng, Z-J Ye, X-J He, Antitumor quinazoline alkaloids from the seeds of Peganum harmala. J Asian Nat Prod Res 2015, 17, 595.
         | Antitumor quinazoline alkaloids from the seeds of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[80]  J Gao, Y-L Zhang, X-Z Miao, X Zhang, J Yuan, J-L Wang, C-M Zheng, Y-G Liu, P Tan, Identification of alkaloids in seeds of Peganum harmala Linn. and analysis of their fragmentation pathways by LTQ‐Orbitrap MS. J Chin Mass Spectrom Soc 2017, 38, 90.[In Chinese]

[81]  MRF Pratama, TA Nasibova, D Pratiwi, P Kumar, EA Garaev, Peganum harmala and its alkaloids as dopamine receptor antagonists: in silico study. Biointerface Res Appl Chem 2020, 11, 10301.
         | Peganum harmala and its alkaloids as dopamine receptor antagonists: in silico study.Crossref | GoogleScholarGoogle Scholar |

[82]  RW Soukup, On the occasion of the 100th anniversary: Ernst Späth and his mescaline synthesis of 1919. Monatsh Chem 2019, 150, 949.
         | On the occasion of the 100th anniversary: Ernst Späth and his mescaline synthesis of 1919.Crossref | GoogleScholarGoogle Scholar |

[83]  WJ Perkin, R Robinson, CXC. – Harmine and harmaline. Part I. Chem Soc Trans 1912, 101, 1775.
         | CXC. – Harmine and harmaline. Part I.Crossref | GoogleScholarGoogle Scholar |

[84]  RHF Manske, WH Perkin, R Robinson, I. – Harmine and harmaline. Part IX. A synthesis of harmaline. J Chem Soc 1927, 0, 1.
         | I. – Harmine and harmaline. Part IX. A synthesis of harmaline.Crossref | GoogleScholarGoogle Scholar |

[85]  S Siddiqui, OY Khan, S Faizi, BS Siddiqui, Studies of the chemical constitutions of the seeds of Peganum harmala; isolation and structure elucidation of two β-carbolines – harmalacine and norharmine. Heterocycles 1989, 29, 521.
         | Studies of the chemical constitutions of the seeds of Peganum harmala; isolation and structure elucidation of two β-carbolines – harmalacine and norharmine.Crossref | GoogleScholarGoogle Scholar |

[86]  J Sapi, D Patigny, J-Y Laronze, Isoharmine revisited: thermal rearrangement of a 3-cyanomethyl-2-vinylindole. Heterocycles 1999, 51, 361.
         | Isoharmine revisited: thermal rearrangement of a 3-cyanomethyl-2-vinylindole.Crossref | GoogleScholarGoogle Scholar |

[87]  MT Ayoub, LJ Rashan, Isoharmine, a β-carboline alkaloid from Peganum harmala seeds. Phytochemistry 1991, 30, 1046.
         | Isoharmine, a β-carboline alkaloid from Peganum harmala seeds.Crossref | GoogleScholarGoogle Scholar |

[88]  T Herraiz, D González, C Ancín-Azpilicueta, VJ Arán, H Guillén, β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol 2010, 48, 839.
         | β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).Crossref | GoogleScholarGoogle Scholar |

[89]  L Liu, T Zhao, XM Cheng, CH Wang, ZT Wang, Characterization and determination of trace alkaloids in seeds extracts from Peganum harmala linn. Using LC-ESI-MS and HPLC. Acta Chromatogr 2013, 25, 221.
         | Characterization and determination of trace alkaloids in seeds extracts from Peganum harmala linn. Using LC-ESI-MS and HPLC.Crossref | GoogleScholarGoogle Scholar |

[90]  AJ Blackman, DJ Matthews, CK Narkowicz, β-Carboline alkaloids from the marine bryozoan Costaticella hastata. J Nat Prod 1987, 50, 494.
         | β-Carboline alkaloids from the marine bryozoan Costaticella hastata.Crossref | GoogleScholarGoogle Scholar |

[91]  Y Su, J-J Xu, J-L Bi, Y-H Wang, G-W Hu, J Yang, G-F Yin, C-L Long, Chemical constituents of Arisaema franchetianum tubers. J Asian Nat Prod Res 2013, 15, 71.
         | Chemical constituents of Arisaema franchetianum tubers.Crossref | GoogleScholarGoogle Scholar |

[92]  J-BS Anouhe, AA Adima, FB Niamké, D Stien, BK Amian, P-A Blandinières, D Virieux, J-L Pirat, S Kati-Coulibaly, N Amusant, Dicorynamine and harmalan-N-oxide, two new β-carboline alkaloids from Dicorynia guianensis Amsh heartwood. Phytochem Lett 2015, 12, 158.
         | Dicorynamine and harmalan-N-oxide, two new β-carboline alkaloids from Dicorynia guianensis Amsh heartwood.Crossref | GoogleScholarGoogle Scholar |

[93]  Y Cui, N Shen, J Dang, L Mei, Y Tao, Z Liu, Anti-inflammatory bioactive equivalence of combinatorial components β-carboline alkaloids identified in Arenaria kansuensis by two-dimensional chromatography and solid-phase extraction coupled with liquid–liquid extraction enrichment technology. J Sep Sci 2017, 40, 2895.
         | Anti-inflammatory bioactive equivalence of combinatorial components β-carboline alkaloids identified in Arenaria kansuensis by two-dimensional chromatography and solid-phase extraction coupled with liquid–liquid extraction enrichment technology.Crossref | GoogleScholarGoogle Scholar |

[94]  M-X Yuan, Y Qiu, Y-Q Ran, G-K Feng, R Deng, X-F Zhu, W-J Lan, H-J Li, Exploration of indole alkaloids from marine fungus Pseudallescheria boydii F44-1 using an amino acid-directed strategy. Mar Drugs 2019, 17, 77.
         | Exploration of indole alkaloids from marine fungus Pseudallescheria boydii F44-1 using an amino acid-directed strategy. Crossref | GoogleScholarGoogle Scholar |

[95]  F Blei, S Dörner, J Fricke, F Baldeweg, F Trottmann, A Komor, F Meyer, C Hertweck, D Hoffmeister, Simultaneous production of psilocybin and a cocktail of β-carboline monoamine oxidase inhibitors in “magic” mushrooms. Chem Eur J 2020, 26, 729.
         | Simultaneous production of psilocybin and a cocktail of β-carboline monoamine oxidase inhibitors in “magic” mushrooms.Crossref | GoogleScholarGoogle Scholar |

[96]  G Kleks, S Duffy, L Lucantoni, VM Avery, AR Carroll, Orthoscuticellines A–E, β-carboline alkaloids from the bryozoan Orthoscuticella ventricosa collected in Australia. J Nat Prod 2020, 83, 422.
         | Orthoscuticellines A–E, β-carboline alkaloids from the bryozoan Orthoscuticella ventricosa collected in Australia.Crossref | GoogleScholarGoogle Scholar |

[97]  M-L Yang, P-C Kuo, T-L Hwang, T-S Wu, Anti-inflammatory principles from Cordyceps sinensis. J Nat Prod 2011, 74, 1996.
         | Anti-inflammatory principles from Cordyceps sinensis.Crossref | GoogleScholarGoogle Scholar |

[98]  Y Hashimoto, K Kawanishi, New alkaloids from Banisteriopsis caapi. Phytochemistry 1976, 15, 1559.
         | New alkaloids from Banisteriopsis caapi.Crossref | GoogleScholarGoogle Scholar |

[99]  Y Hashimoto, K Kawanishi, New organic bases from amazonian Banisteriopsis caapi. Phytochemistry 1975, 14, 1633.
         | New organic bases from amazonian Banisteriopsis caapi.Crossref | GoogleScholarGoogle Scholar |

[100]  L Nettleship, M Slaytor, Ruine: a glucosidic β-carboline from Peganum harmala Phytochemistry 1971, 10, 231.
         | Ruine: a glucosidic β-carboline from Peganum harmalaCrossref | GoogleScholarGoogle Scholar |

[101]  L Nettleship, M Slaytor, Adaptation of Peganum harmala Callus to alkaloid production. J Exp Bot 1974, 25, 1114.
         | Adaptation of Peganum harmala Callus to alkaloid production.Crossref | GoogleScholarGoogle Scholar |

[102]  Fr Goebel, Ueber das Harmalin. Ann Chem Pharm 1841, 38, 363.[In German]
         | Ueber das Harmalin.Crossref | GoogleScholarGoogle Scholar |

[103]  FMA Bar, M Sameti, AI Foudah, A Haque, M Elsbaey, In vitro and in silico inhibition of COX-2 and 5-LOX by beta-carboline alkaloids from the seeds of Peganum harmala L. S Afr J Bot 2022, 147, 926.
         | In vitro and in silico inhibition of COX-2 and 5-LOX by beta-carboline alkaloids from the seeds of Peganum harmala L.Crossref | GoogleScholarGoogle Scholar |

[104]  SA Fahmy, MY Issa, BM Saleh, MR Meselhy, HME-S Azzazy, Peganum harmala alkaloids self-assembled supramolecular nanocapsules with enhanced antioxidant and cytotoxic activities. ACS Omega 2021, 6, 11954.
         | Peganum harmala alkaloids self-assembled supramolecular nanocapsules with enhanced antioxidant and cytotoxic activities.Crossref | GoogleScholarGoogle Scholar |

[105]  FA Hochstein, AM Paradies, Alkaloids of Banisteria caapi and Prestonia amazonicum. J Am Chem Soc 1957, 79, 5735.
         | Alkaloids of Banisteria caapi and Prestonia amazonicum.Crossref | GoogleScholarGoogle Scholar |

[106]  GM Badger, AF Beecham, Isolation of tetrahydroharman from Petalostyles labicheoides. Nature 1951, 168, 517.
         | Isolation of tetrahydroharman from Petalostyles labicheoides.Crossref | GoogleScholarGoogle Scholar |

[107]  PS Massagetov, Alkaloids in plants of the family Eleagnaceae. Zh Obshch Khim 1946, 16, 139.[In Russian]

[108]  S Siddiqui, O Yusuf Khan, S Faizi, BS Siddiqui, Studies on the chemical constituents of the seeds of Peganum harmala – isolation and structure of a new β-carboline alkaloid – harmalicine. Heterocycles 1987, 26, 1563.
         | Studies on the chemical constituents of the seeds of Peganum harmala – isolation and structure of a new β-carboline alkaloid – harmalicine.Crossref | GoogleScholarGoogle Scholar |

[109]  S Siddiqui, O Yusuf Khan, S Faizi, B Shaheen Siddiqui, Studies in the chemical constituents of the seeds of Pegnum harmala: isolation and structure elucidation of two β-carboline lactams – harmalanine and harmalacidine. Heterocycles 1988, 27, 1401.
         | Studies in the chemical constituents of the seeds of Pegnum harmala: isolation and structure elucidation of two β-carboline lactams – harmalanine and harmalacidine.Crossref | GoogleScholarGoogle Scholar |

[110]  S Siddiqui, OY Khan, BS Siddiqui, S Faizi, Harmalidine, a β-carboline alkaloid from Peganum harmala. Phytochemistry 1987, 26, 1548.
         | Harmalidine, a β-carboline alkaloid from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[111]  Z-Z Ma, Y Hano, T Nomura, Y-J Chen, Alkaloids and phenylpropanoids from Peganum nigellastrum. Phytochemistry 2000, 53, 1075.
         | Alkaloids and phenylpropanoids from Peganum nigellastrum.Crossref | GoogleScholarGoogle Scholar |

[112]  K-B Wang, Y-T Di, Y Bao, C-M Yuan, G Chen, D-H Li, J Bai, H-P He, X-J Hao, Y-H Pei, Y-K Jing, Z-L Li, H-M Hua, Peganumine A, a β-carboline dimer with a new octacyclic scaffold from Peganum harmala. Org Lett 2014, 16, 4028.
         | Peganumine A, a β-carboline dimer with a new octacyclic scaffold from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[113]  Y Xu, X Zhao, D Zhang, Z-Y Yang, C-Y Xu, J Liu, L Fang, New β-carboline alkaloids from the seeds of Peganum harmala. Phytochem Lett 2023, 53, 166.
         | New β-carboline alkaloids from the seeds of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[114]  D Tarkowská, A fast and reliable UHPLC–MS/MS-based method for screening selected pharmacologically significant natural plant indole alkaloids Molecules 2020, 25, 3274.
         | A fast and reliable UHPLC–MS/MS-based method for screening selected pharmacologically significant natural plant indole alkaloidsCrossref | GoogleScholarGoogle Scholar |

[115]  Z-N Wu, N-H Chen, Q Tang, S Chen, Z-C Zhan, Y-B Zhang, G-C Wang, Y-L Li, W-C Ye, β-Carboline alkaloids from the seeds of Peganum harmala and their anti-HSV-2 virus activities. Org Lett 2020, 22, 7310.
         | β-Carboline alkaloids from the seeds of Peganum harmala and their anti-HSV-2 virus activities.Crossref | GoogleScholarGoogle Scholar |

[116]  K-B Wang, C-M Yuan, C-M Xue, D-H Li, Y-K Jing, H-P He, X-J Hao, Y-T Di, Z-L Li, H-M Hua, Pegaharmalines A and B, two novel β-carboline alkaloids with unprecedented carbon skeletons from Peganum harmala. RSC Adv 2014, 4, 53725.
         | Pegaharmalines A and B, two novel β-carboline alkaloids with unprecedented carbon skeletons from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[117]  K-B Wang, S-G Li, X-Y Huang, D-H Li, Z-L Li, H-M Hua, (±)-Peharmaline A: a pair of rare β-carboline–vasicinone hybrid alkaloid enantiomers from Peganum harmala. Eur J Org Chem 2017, 2017, 1876.
         | (±)-Peharmaline A: a pair of rare β-carboline–vasicinone hybrid alkaloid enantiomers from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[118]  S-G Li, Y-T Wang, Q Zhang, K-B Wang, J-J Xue, D-H Li, Y-K Jing, B Lin, H-M Hua, Pegaharmols A–B, axially chiral β-carboline-quinazoline dimers from the roots of Peganum harmala. Org Lett 2020, 22, 7522.
         | Pegaharmols A–B, axially chiral β-carboline-quinazoline dimers from the roots of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[119]  S-L Li, X Hu, Q Zhang, Y-H Zan, K-B Wang, C-Y Jiang, J-J Xue, Y-X Liu, B Lin, Y-K Jing, D-H Li, H-M Hua, (±)-Pheharmines A–B, two pairs of racemic alkaloids with a morpholino[4,3,2-hi]β-carboline core, from the roots of Peganum harmala. Org Biomol Chem 2022, 20, 8528.
         | (±)-Pheharmines A–B, two pairs of racemic alkaloids with a morpholino[4,3,2-hi]β-carboline core, from the roots of Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[120]  DJ McKenna, GHN Towers, F Abbott, Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of Ayahuasca. J Ethnopharmacol 1984, 10, 195.
         | Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of Ayahuasca.Crossref | GoogleScholarGoogle Scholar |

[121]  H Rommelspacher, T May, B Salewski, Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur J Pharmacol 1994, 252, 51.
         | Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats.Crossref | GoogleScholarGoogle Scholar |

[122]  B Jiang, S Li, W Liu, Y Yang, W Chen, D He, X Cheng, Z Wang, W Chen, C Wang, Inhibitive activities detection of monoamine oxidases (MAO) A and B inhibitors in human liver MAO incubations by UPLC–ESI-MS/MS. J Pharm Biomed Anal 2015, 115, 283.
         | Inhibitive activities detection of monoamine oxidases (MAO) A and B inhibitors in human liver MAO incubations by UPLC–ESI-MS/MS.Crossref | GoogleScholarGoogle Scholar |

[123]  V Samoylenko, MdM Rahman, BL Tekwani, LM Tripathi, Y-H Wang, SI Khan, IA Khan, LS Miller, VC Joshi, I Muhammad, Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease. J Ethnopharmacol 2010, 127, 357.
         | Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease.Crossref | GoogleScholarGoogle Scholar |

[124]  WM McIsaac, V Estevez, Structure-action relationship of β-carbolines as monoamine oxidase inhibitors. Biochem Pharmacol 1966, 15, 1625.
         | Structure-action relationship of β-carbolines as monoamine oxidase inhibitors.Crossref | GoogleScholarGoogle Scholar |

[125]  JC Callaway, DJ McKenna, CS Grob, GS Brito, LP Raymon, RE Poland, EN Andrade, EO Andrade, DC Mash, Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol 1999, 65, 243.
         | Pharmacokinetics of Hoasca alkaloids in healthy humans.Crossref | GoogleScholarGoogle Scholar |

[126]  B Grella, M Dukat, R Young, M Teitler, K Herrick-Davis, CB Gauthier, RA Glennon, Investigation of hallucinogenic and related β-carbolines. Drug Alcohol Depend 1998, 50, 99.
         | Investigation of hallucinogenic and related β-carbolines.Crossref | GoogleScholarGoogle Scholar |

[127]  H Rommelspacher, T May, R Susilo, β-Carbolines and tetrahydroisoquinolines: detection and function in mammals. Planta Med 1991, 57, S85.
         | β-Carbolines and tetrahydroisoquinolines: detection and function in mammals.Crossref | GoogleScholarGoogle Scholar |

[128]  D Fekkes, MJ Schouten, L Pepplinkhuizen, J Bruinvels, W Lauwers, UdoA Brinkman, Norharman, a normal body constituent. Lancet 1992, 339, 506.
         | Norharman, a normal body constituent.Crossref | GoogleScholarGoogle Scholar |

[129]  W Zheng, S Wang, LF Barnes, Y Guan, ED Louis, Determination of harmane and harmine in human blood using reversed-phased high-performance liquid chromatography and fluorescence detection. Anal Biochem 2000, 279, 125.
         | Determination of harmane and harmine in human blood using reversed-phased high-performance liquid chromatography and fluorescence detection.Crossref | GoogleScholarGoogle Scholar |

[130]  W Pfau, K Skog, Exposure to β-carbolines norharman and harman. J Chromatogr B 2004, 802, 115.
         | Exposure to β-carbolines norharman and harman.Crossref | GoogleScholarGoogle Scholar |

[131]  JH Halpern, Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 2004, 102, 131.
         | Hallucinogens and dissociative agents naturally growing in the United States.Crossref | GoogleScholarGoogle Scholar |

[132]  R Asadzadeh, N Abbasi, M Bahmani, Extraction and identification of chemical compounds of Peganum harmala L. seed essential oil by HS-SPME and GC-MS methods. Trad Integr Med 2021, 229.
         | Extraction and identification of chemical compounds of Peganum harmala L. seed essential oil by HS-SPME and GC-MS methods.Crossref | GoogleScholarGoogle Scholar |

[133]  I Apostolico, L Aliberti, L Caputo, V De Feo, F Fratianni, F Nazzaro, LF Souza, M Khadhr, Chemical composition, antibacterial and phytotoxic sctivities of Peganum harmala seed essential oils from five different localities in northern Africa. Molecules 2016, 21, 1235.
         | Chemical composition, antibacterial and phytotoxic sctivities of Peganum harmala seed essential oils from five different localities in northern Africa.Crossref | GoogleScholarGoogle Scholar |

[134]  G Li, B Ying, D Liu, The isolation and structural determination of γ‐harmaline from the seed of Peganum harmala L. Zhíwùxué Bào 1989, 31, 393.[In Chinese]

[135]  MV Tekzhenetskaya, B Tashkhodzhaev, MR Yagudaev, BT Ibragimov, SYu Yunusov, Structure of vasicol. Chem Nat Compd 1989, 25, 14.
         | Structure of vasicol.Crossref | GoogleScholarGoogle Scholar |

[136]  N Wang, J An, Z Zhang, Y Liu, J Fang, Z Yang, The antimicrobial activity and characterization of bioactive compounds in Peganum harmala L. based on HPLC and HS-SPME-GC-MS. Front Microbiol 2022, 13, 916371.
         | The antimicrobial activity and characterization of bioactive compounds in Peganum harmala L. based on HPLC and HS-SPME-GC-MS.Crossref | GoogleScholarGoogle Scholar |

[137]  Z Fan, X Yao, An oxamide from Peganum harmala seeds. J China Pharm Univ 1992, 2, 144.

[138]  MT Ayoub, LJ Rashan, AT Khazraji, MH Adaay, Phytochemistry 1989, 28, 2000.
         | Crossref | GoogleScholarGoogle Scholar |

[139]  Abdel Aziz HG, Abdel Kader SM, El-Sayed MM, EL-Malt EA, Shaker ES. Novel β-carboline alkaloid from Peganum harmala as antibacterial agent. Proceedings of the Tenth Radiation Physics and Protection Conference, Cairo, Egypt; 27–30 Nov 2010; 2011. p. 402.

[140]  C Wang, Z Zhang, Y Wang, X He, Cytotoxic constituents and mechanism from Peganum harmala. Chem Biodivers 2016, 13, 961.
         | Cytotoxic constituents and mechanism from Peganum harmala.Crossref | GoogleScholarGoogle Scholar |

[141]  Y Li, Q He, S Du, S Guo, Z Geng, Z Deng, Study of methanol extracts from different parts of Peganum harmala L. using 1H-NMR plant metabolomics. J Anal Methods Chem 2018, 2018, e6532789.
         | Study of methanol extracts from different parts of Peganum harmala L. using ¹H-NMR plant metabolomics.Crossref | GoogleScholarGoogle Scholar |